Stocktoria
Context Therapeutics Inc. CNTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-10-20
Chart by TradingView
1/9
Piotroski F — financial health
3.57
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$39.7M | -$29.9M | -$25.1M | -$15.4M | -$10.5M |
| Net income | -$36.1M | -$26.7M | -$24.0M | -$14.8M | -$10.5M |
| Operating cash flow | -$26.4M | -$14.6M | -$21.0M | -$13.5M | -$8.8M |
| Free cash flow | -$26.4M | -$14.6M | -$21.0M | -$13.6M | -$8.8M |
| Total assets | $68.5M | $98.1M | $16.1M | $38.0M | $51.3M |
| Total liabilities | $8.0M | $2.9M | $4.2M | $3.2M | $3.0M |
| Shareholders' equity | $60.5M | $95.3M | $11.9M | $34.8M | $48.3M |
| Ratios | |||||
| Return on assets | -52.7% | -27.2% | -149.2% | -39.1% | -20.4% |
| Return on equity | -59.7% | -28.1% | -201.9% | -42.7% | -21.7% |
| Current ratio | 8.52 | 35.62 | 3.83 | 11.80 | 16.90 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 182,999 | $479,457 |
| Point72 Asset Management, L.P. | 57,231 | $149,945 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.57 (safe)
- Working capital / assets 0.881
- Retained earnings / assets -1.911
- EBIT / assets -0.58
- Equity / liabilities 7.54
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001842952 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.